Form 4: NHI Director Exercises Options, Adjusts Holdings
Insider Transaction Report
National Health Investors Director Robert G. Adams exercised stock options and adjusted his beneficial ownership of common stock.
Summary
- Robert G. Adams, a Director of National Health Investors Inc. (NHI), engaged in multiple transactions on January 27, 2026.
- Exercised options to acquire 25,000 shares of common stock at an exercise price of $69.20 per share.
- Exercised options to acquire an additional 10,000 shares of common stock at an exercise price of $73.34 per share.
- Disposed of 31,093 shares of common stock at a price of $79.23 per share, likely for tax withholding purposes related to the option exercises.
- Following these transactions, Adams indirectly holds a total of 566,551 shares of common stock through various trusts and partnerships.
Sentiment
Score: 7
Explanation: StockSavvy.ai views this as a moderately positive signal, as a director is increasing their stake in the company through option exercises, indicating confidence, despite a portion being sold for tax purposes.
Positives
- Director Adams exercised a significant number of stock options (35,000 shares), indicating confidence in the company's future value.
- The exercise prices ($69.20 and $73.34) were below the disposition price ($79.23), suggesting a profitable transaction for the director.
Negatives
- A portion of the acquired shares (31,093 shares) was immediately disposed of, likely to cover taxes, which reduces the net increase in the director's beneficial ownership.
Future Outlook
NA
Industry Context
StockSavvy.ai notes that insider buying, particularly through option exercises, can signal management's positive outlook on the company's future performance within the healthcare REIT sector. The disposition of shares for tax purposes is a common practice and does not necessarily indicate a negative sentiment.
Stakeholder Impact
- Shareholders may view the director's option exercise as a positive signal of management confidence in the company's future prospects.
- The transactions do not directly impact employees, customers, suppliers, or creditors in a material way beyond general market sentiment.
Key Dates
| Date | Description |
|---|---|
| 02/25/2021 | Grant date for 25,000 stock options with an exercise price of $69.20. |
| 03/03/2025 | Grant date for 10,000 stock options with an exercise price of $73.34. |
| 01/27/2026 | Date of stock option exercises and common stock disposition. |
| 01/29/2026 | Signature date of the reporting person. |
| 02/25/2026 | Expiration date for 25,000 stock options. |
| 03/03/2030 | Expiration date for 10,000 stock options. |
Recommendation
holdThe filing details routine insider transactions involving option exercises and subsequent sales for tax purposes. While the exercise indicates director confidence, the overall impact on the company's fundamentals or strategic direction is minimal. It does not present new information warranting a change from a 'hold' position, as it's an expected part of executive compensation and personal financial management.
Keywords
National Health Investors, NHI, Insider Trading, Form 4, Stock Options, Director Transactions, Beneficial Ownership, Healthcare REIT
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.